Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Esther M A Maciel

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Current Neuropharmacology|June 5, 2019
Synaptic Elimination in Neurological DisordersPablo L Cardozo, Izabella B Q de Lima, Esther M A Maciel, et al.
Scientific Reports|June 1, 2022
mGluR5 ablation leads to age-related synaptic plasticity impairments and does not improve Huntington's disease phenotypeJessica M de Souza, Talita H Ferreira-Vieira, Esther M A Maciel, et al.
Journal of Neurochemistry|July 21, 2018
The mGluR5 positive allosteric modulator VU0409551 improves synaptic plasticity and memory of a mouse model of Huntington's diseaseJuliana G Doria, Jessica M de Souza, Flavia R Silva, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Current Neuropharmacology|June 5, 2019
Synaptic Elimination in Neurological DisordersPablo L Cardozo, Izabella B Q de Lima, Esther M A Maciel, et al.
Scientific Reports|June 1, 2022
mGluR5 ablation leads to age-related synaptic plasticity impairments and does not improve Huntington's disease phenotypeJessica M de Souza, Talita H Ferreira-Vieira, Esther M A Maciel, et al.
Journal of Neurochemistry|July 21, 2018
The mGluR5 positive allosteric modulator VU0409551 improves synaptic plasticity and memory of a mouse model of Huntington's diseaseJuliana G Doria, Jessica M de Souza, Flavia R Silva, et al.
Pageof 1